Skip to main content
logo
Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.15
-0.11 (-0.90%)
At close: Oct 30, 2026, 4:00 PM EDT
12.17
+0.02 (0.16%)
After-hours: Oct 30, 2026, 7:30 PM EDT

Medifast Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-40.85-18.672.0999.42143.57164.03
Depreciation & Amortization
12.7614.2412.7113.1110.986.81
Loss (Gain) From Sale of Assets
-1.391.370.091.172.130
Asset Writedown & Restructuring Costs
10.83-----
Loss (Gain) From Sale of Investments
-0.66-43.2-0.320.010.09
Stock-Based Compensation
7.747.647.368.1911.059.9
Other Operating Activities
16.7716.088.785.825.171.35
Change in Inventory
222.1912.1764.2761.19-126.65
Change in Accounts Payable
-7.24-23.91-34.99-35.71-37.5954.38
Change in Income Taxes
0.21-6.610.21-9.161.37-0.95
Change in Other Net Operating Assets
-0.19-1.482.870.87-3.32-14.43
Operating Cash Flow
-0.036.8624.48147.66194.5794.55
Operating Cash Flow Growth
--71.96%-83.42%-24.11%105.80%-34.88%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.84-5.61-7.45-6.48-16.68-34.21
Sale of Property, Plant & Equipment
3.64-----
Investment in Securities
-39.93-2.31-19.07-54.565.275.15
Investing Cash Flow
-40.14-7.93-26.52-61.05-11.41-29.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
--0.040.19-0.81
Repurchase of Common Stock
-0.82-0.37-0.84-6.96-127.96-62.09
Common Dividends Paid
-0.17-0.2-0.72-73.02-71.62-63.86
Financing Cash Flow
-0.99-0.56-1.52-79.79-199.58-125.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
000.05-0.07-0.070.11
Net Cash Flow
-41.15-1.63-3.516.75-16.49-59.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3.871.2517.02141.17177.8960.34
Free Cash Flow Growth
--92.66%-87.94%-20.64%194.83%-56.69%
Free Cash Flow Margin
-1.29%0.32%2.83%13.17%11.13%3.95%
Free Cash Flow Per Share
-0.350.111.5512.9315.785.11
Levered Free Cash Flow
-2.615.4115.72106.22154.4635.66
Unlevered Free Cash Flow
-2.615.4115.72106.22154.8935.81

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.6710.47-1.6234.2637.2156.76
Change in Working Capital
-5.22-9.81-9.7520.2821.65-87.65
SEC Filings: 10-K · 10-Q